Načítá se...
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
The microglial receptors, CD33 and TREM2, have been associated with risk for Alzheimer’s disease (AD). Here, we investigated crosstalk between CD33 and TREM2. We showed that knock-out of CD33 attenuated amyloid beta (Aβ) pathology and improved cognition in 5xFAD mice, both of which were abrogated by...
Uloženo v:
| Vydáno v: | Neuron |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728215/ https://ncbi.nlm.nih.gov/pubmed/31301936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuron.2019.06.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|